Episode 4 - SUGAR DIP TRIAL 2025 Podcast Por  arte de portada

Episode 4 - SUGAR DIP TRIAL 2025

Episode 4 - SUGAR DIP TRIAL 2025

Escúchala gratis

Ver detalles del espectáculo
OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.

The SUGAR-DIP Trial examines whether a sequential oral medication strategy (Metformin + Glyburide) is non-inferior to insulin for preventing large-for-gestational-age (LGA) infants in gestational diabetes. This episode explores:

  • The efficacy of oral agents vs. insulin in glycemic control
  • Differences in neonatal outcomes, maternal hypoglycemia, and birth complications
  • Why insulin remains the gold standard in gestational diabetes
  • Future prospects for oral therapy in pregnancy
Todavía no hay opiniones